Introduction to Bioequivalence and Therapeutic Equivalence 2013 is a webinar that covers topics such as:
- Relationships among bioequivalence, pharmaceutical equivalence and therapeutic equivalence
- FDA requirements for a successful ANDA by demonstrating bioequivalence for drug products
- Equivalency considerations for critical dose and modified release pharmaceutical products
- FDA Orange Book coding of equivalence
Introduction to Bioequivalence and Therapeutic Equivalence 2013 brings together Personnel in the biotechnology, pharmaceutical and biologics industries with responsibility for:
- Marketing
- Regulatory affairs
- Product development
- Clinical development
- Risk Management
- Quality Assurance
- Clinical Research
